Latest Articles

Publication Date
Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived ε‑viniferin in human endometrial cells:  A potential therapy for endometriosis.

Endometriosis is a chronic gynecological disorder characterized by the ectopic growth and proliferation of endometrial tissue outside the uterine cavity, leading to inflammation. Although low‑dose contraceptive pills are widely used …

Published: Aug. 8, 2025, midnight
C57BL/6J mice best recapitulate fibrosis and inflammatory pathophysiology in syngeneic mouse model of endometriosis.

Endometriosis (ENDO), a chronic inflammatory disease affecting approximately 190 million women globally, is characterized by fibrosis, a feature often challenging to replicate in murine models. To identify an optimal syngeneic …

Published: Aug. 8, 2025, midnight
New treatment offers hope for women with advanced womb cancer - Irish Star

New treatment offers hope for women with advanced womb cancer Irish Star

Published: Aug. 7, 2025, noon
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes

NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes

Published: Aug. 7, 2025, 9:15 a.m.
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis - Frontiers

Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis Frontiers

Published: Aug. 7, 2025, 7:56 a.m.
Cartherics opens advanced cell therapy manufacturing facility in Victoria - Australian Manufacturing

Cartherics opens advanced cell therapy manufacturing facility in Victoria Australian Manufacturing

Published: Aug. 7, 2025, 1:04 a.m.
Treatment for advanced womb cancer ‘major step forward’ - MSN

Treatment for advanced womb cancer ‘major step forward’ MSN

Published: Aug. 7, 2025, 12:44 a.m.
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers - The ASCO Post

Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers The ASCO Post

Published: Aug. 6, 2025, 3:38 p.m.
New NHS Drug Option for Advanced Endometrial Cancer - Medscape

New NHS Drug Option for Advanced Endometrial Cancer Medscape

Published: Aug. 6, 2025, 10:54 a.m.
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer - NAVLIN DAILY

NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer NAVLIN DAILY

Published: Aug. 6, 2025, 9:30 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!